Date: 19.6.2020
Summary:
A German university offers chimeric mutants of interferon alpha 2 and other interferon alpha subtypes with improved antiviral activity for treatment of chronic or acute viral infections, bacterial or parasitic infections or tumour therapy. These interferons are characterized by a high biocompatibility. The university offers license agreements.
Reference: TODE20200519003
Country: Germany
Submitted: 19. 6. 2020
Keywords
Technology: Cytology, Cancerology, Oncology; Pharmaceutical Products / Drugs; Virus, Virology/Antibiotics/Bacteriology
Market: Oncology; Other clinical medicine; Pharmaceuticals/fine chemicals
NACE: -
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Práce - Nabidky prace
Cancer cells - Czech Scientists are Working to Find the Achilles†Heel of Cancer Cells
Researchers develop electronic soil that enhances crop growth
Biocompatible nanoparticles modified with ATP can enhance systemic delivery of cancer immunotherapy